HistoIndex, a Singapore-based medtech/healthcare company that specialises in its proprietary integrated stain-free artificial intelligence (AI) digital pathology platform, has announced that Sim Giok Lak has decided to step down as Non-Executive Chairman of the Board; and Dr David John Jeans CBE has been appointed as the Non-Executive Chairman of the Board.

Since the incorporation of the Company, Sim Giok Lak has guided HistoIndex with his wealth of industrial and corporate experiences. He will remain as a Non-Executive Director on the Board as well as Non-Executive Chairman of Choutu Technology, a wholly owned subsidiary of HistoIndex that is based in Hangzhou, China.

Dr Jeans was first appointed to the Board as a non-executive director on 17th May 2022. He has helmed senior leadership positions in international healthcare corporations such as Bristol Myers Squibb and Johnson & Johnson. He was previously the Chairman of Cardiff University, Deputy Chief Executive of the UK Medical Research Council, chaired the Trustee Board of MRC Technology, involved in the Science Advisory Council for Wales, and served as Trustee of the Francis Crick Institute. He is currently the Chairman of the Digital Health & Care Innovation Centre in Scotlandand in Singapore. Dr Jeans is a co-Chair of the Strategic Advisory Panel at the Diagnostics Development Hub (DxD Hub). In 2012, he was awarded the Commander of the Order of the British Empire (CBE) for his significant contributions to Life Sciences, Healthcare and Science.